PubMed
Ciliary neurotrophic factor (CNTF) and related peptides in neuroprotection
Peterson et al., 2013
Neurological & CognitiveResearch OnlyD
P21
Nootropic Peptide Candidate
Experimental neurocognitive peptide candidate with limited human evidence.
Observational report only — live community data. Not medical advice. Does not recommend doses, protocols, or treatments.
- Studies cited
- 3
- Research grade
- D
- Experience
- 100
- Activity
- 84
Overall check-ins
Trackers & reports
Overview
About P21
Experimental neurocognitive peptide candidate with limited human evidence.
- Category
- Neurological & Cognitive
- Regulatory status
- Research Only
- Also known as
- Nootropic Peptide Candidate
- Self-reports
- 6
Community
What 6 users report
6 community reports
Overall experience
From check-in ratings — separate from side effects logged below. Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.
Favorable 100% · Mixed 0% · Unfavorable overall 0%
Most reported benefits
Benefits users selected when logging a favorable or mixed check-in.
Cognition
6
Mood
6
Sleep
3
Self-reported dose per injection
Median bucket: 200–400 mcg · Most common: 200–400 mcg
Reports span 100–400 mcg
100–200
2
200–400
4
Anonymized self-reports from PeptIQ users — not prescribing guidance. Buckets group similar logged amounts; open-ended top buckets mean “at least” that dose.
Commonly stacked with
Research
Cited research (2)
Source
PubMed
The effect of exogenous ciliary neurotrophic factor on cell cycle and neural differentiation markers of in vitro model cells: New insights for future therapeutic approaches
Ghasemi et al., 2021
Tools
Explore more
Explore
More ways to learn about P21 from observational PeptIQ data.
Compare with
Related peptides
Help
Frequently asked
What do PeptIQ users report about P21?
This page summarizes 6 anonymized self-reports from PeptIQ users who track P21, including commonly reported effects and co-tracked peptides. These are observational patterns, not clinical outcomes.
How do side effects relate to overall experience for P21?
PeptIQ separates overall check-in ratings (favorable, mixed, or unfavorable) from logged side effects like nausea or fatigue. Users often report benefits and side effects in the same check-in — a high experience score does not mean zero side effects were noted.
What research is cited for P21?
2 sources are linked on this page, including PubMed articles, clinical trial registries, and FDA labels where applicable. Citations describe published research — not recommendations.
Is P21 safe to use?
This wiki does not assess safety or recommend use. P21 is listed as Research Only. Consult a licensed clinician for personal medical decisions.
What are the purported benefits and uses of P21?
This wiki summarizes observational community reports and linked citations for P21. It does not assert therapeutic benefits. See the cited research list on this page and the educational profile for P21 for study-level context — not medical advice.
What is the legal status of P21?
P21 is listed in PeptIQ as Research Only. Regulatory status varies by jurisdiction and can change. This wiki does not provide legal advice; check current FDA and local rules and talk with a licensed clinician or counsel for personal decisions.
What are the known or theoretical side effects and risks of P21?
Safety data quality for P21 varies widely by compound and study design. PeptIQ does not establish a risk profile here. Review primary literature, product labeling where applicable, and clinician guidance. Community self-reports are not a substitute for clinical evidence.
What is the current state of research on P21?
This page links 2 indexed sources for P21. Evidence maturity differs by application — some peptides have large human programs, others are mostly preclinical. Treat citation counts as literature volume, not proof of efficacy.